Classification
- Anatomical main groupNNervous system
- Therapeutic subgroupN01
- Pharmacological subgroupN01B
- Chemical subgroupN01BB
- Chemical substanceN01BB03Mepivacaine
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 13 medicines
FDA · 13 medicines
AIFA · 8 medicines
SFDA · 8 medicines · Historical list
CBG-MEB · 5 medicines
PHARMAC · 4 medicines
HSA · 4 medicines
HALMED · 1 medicine
ALIMS · 1 medicine
TFDA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
13 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Mepivacaine Hydrochloride | United States | 1%, 2%, 3% | injectable | Not marketed | Intl Medication Sys |
| Mepivacaine Hydrochloride W/ LevonordefrinCombination | United States | 0.05MG/ML; 2% | injectable | Not marketed | Belmora LLC |
| Polocaine-MPF | United States | 1.5%, 1%, 2% | injectable | Marketed | Fresenius Kabi USA |
| Polocaine | United States | 1%, 2%, 3% | injectable | Marketed | Fresenius Kabi USA |
| Scandonest Plain | United States | 3% | injectable | Marketed | Deproco |
| Carbocaine | United States | 1.5%, 1%, 2% … | injectable | Not marketed | Eastman Kodak |
| Isocaine Hydrochloride | United States | 3% | injectable | Not marketed | Septodont |
| Arestocaine Hydrochloride | United States | 3% | injectable | Not marketed | Solvay |
| Carbocaine W/ Neo-CobefrinCombination | United States | 0.05MG/ML; 2% | injectable | Not marketed | Eastman Kodak |
| Polocaine W/ LevonordefrinCombination | United States | 0.05MG/ML; 2% | injectable | Not marketed | Dentsply Pharm |
| Isocaine Hydrochloride W/ LevonordefrinCombination | United States | 0.05MG/ML; 2% | injectable | Not marketed | Septodont |
| Arestocaine Hydrochloride W/ LevonordefrinCombination | United States | 0.05MG/ML; 2% | injectable | Not marketed | Solvay |
| Scandonest LCombination | United States | 0.05MG/ML; 2% | injectable | Not marketed | Deproco |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.